{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T13:05:30Z","timestamp":1771074330576,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.vascn.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T01:47:28Z","timestamp":1511142448000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment"],"prefix":"10.1016","volume":"90","author":[{"given":"Derek","family":"Schocken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayna","family":"Stohlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9963-1205","authenticated-orcid":false,"given":"Jose","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulciana","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6507-9771","authenticated-orcid":false,"given":"Dakshesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali Krishna","family":"Matta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Millard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ksenia","family":"Blinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2017.11.002_bb0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.vascn.2016.12.003","article-title":"A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes","volume":"84","author":"Ando","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2017.11.002_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vascn.2015.04.002","article-title":"Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes","volume":"75","author":"Asakura","year":"2015","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2017.11.002_bb0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(80)90540-1","article-title":"Serum-free cell culture: A unifying approach","volume":"22","author":"Barnes","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.vascn.2017.11.002_bb0020","doi-asserted-by":"crossref","first-page":"H44","DOI":"10.1152\/ajpheart.00793.2015","article-title":"High-throughput drug profiling with voltage- and calcium-sensitive fluorescent probes in human iPSC-derived cardiomyocytes","volume":"311","author":"Bedut","year":"2016","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"key":"10.1016\/j.vascn.2017.11.002_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/toxsci\/kfw200","article-title":"Comprehensive translational assessment of human induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias","volume":"155","author":"Blinova","year":"2016","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2017.11.002_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/07435800903204082","article-title":"Effects of resin or charcoal treatment on fetal bovine serum and bovine calf serum","volume":"34","author":"Cao","year":"2009","journal-title":"Endocrine Research"},{"key":"10.1016\/j.vascn.2017.11.002_bb0035","first-page":"kfv180","article-title":"Bridging functional and structural cardiotoxicity assays using human embryonic stem-cell derived cardiomyocytes for a more comprehensive risk assessment","author":"Clements","year":"2015","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2017.11.002_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","article-title":"The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative \u2014 Update on progress","volume":"81","author":"Colatsky","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2017.11.002_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/toxsci\/kfr158","article-title":"Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes","volume":"123","author":"Guo","year":"2011","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2017.11.002_bb0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/toxsci\/kft205","article-title":"Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model","volume":"136","author":"Guo","year":"2013","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2017.11.002_bb0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/toxsci\/kfw171","article-title":"The use of Ratiometric fluorescence measurements of the voltage sensitive dye Di-4-ANEPPS to examine action potential characteristics and drug effects on human induced pluripotent stem cell-derived cardiomyocytes","volume":"154","author":"Hortigon-Vinagre","year":"2016","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2017.11.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfw235","article-title":"Evaluation of batch variations in induced pluripotent stem cell-derived human cardiomyocytes from 2 major suppliers","author":"Huo","year":"2016","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2017.11.002_bb0065","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.hrthm.2006.05.023","article-title":"Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval","volume":"3","author":"Indik","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.vascn.2017.11.002_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018037","article-title":"Calcium handling in human induced pluripotent stem cell derived cardiomyocytes","volume":"6","author":"Itzhaki","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2017.11.002_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.117.305365","article-title":"Human induced pluripotent stem cell\u2013derived cardiomyocytes","volume":"117","author":"Karakikes","year":"2015","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2017.11.002_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/scrt406","article-title":"Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes","volume":"5","author":"Keung","year":"2014","journal-title":"Stem Cell Research & Therapy"},{"key":"10.1016\/j.vascn.2017.11.002_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vascn.2007.01.001","article-title":"The effects of plasma proteins on delayed repolarization in vitro with cisapride, risperidone, and d, l-sotalol","volume":"56","author":"Limberis","year":"2007","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2017.11.002_bb0090","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: Electrophysiological properties of action potentials and ionic currents","volume":"301","author":"Ma","year":"2011","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"key":"10.1016\/j.vascn.2017.11.002_bb0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.stemcr.2015.02.007","article-title":"A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing","volume":"4","author":"Maddah","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.vascn.2017.11.002_bb0100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jps.2600570601","article-title":"The binding of drugs by plasma proteins","volume":"57","author":"Meyer","year":"1968","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.vascn.2017.11.002_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/toxsci\/kfs233","article-title":"Characterization of human-induced pluripotent stem cell\u2013derived cardiomyocytes: Bioenergetics and utilization in safety screening","volume":"130","author":"Rana","year":"2012","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2017.11.002_bb0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium","volume":"167","author":"Sager","year":"2014","journal-title":"American Heart Journal"},{"key":"10.1016\/j.vascn.2017.11.002_bb0115","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/195727","article-title":"Drug solubility: Importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharmaceutics"},{"key":"10.1016\/j.vascn.2017.11.002_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1872312808666141127113055","article-title":"A systematic evaluation of solubility enhancing excipients to enable the generation of permeability data for poorly soluble compounds in Caco-2 model","volume":"8","author":"Shah","year":"2014","journal-title":"Drug Metabolism Letters"},{"key":"10.1016\/j.vascn.2017.11.002_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40264-013-0016-z","article-title":"Dealing with global safety issues: Was the response to QT-liability of non-cardiac drugs well coordinated?","volume":"36","author":"Stockbridge","year":"2013","journal-title":"Drug Safety"},{"key":"10.1016\/j.vascn.2017.11.002_bb0130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.vascn.2017.11.002_bb0135","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.vascn.2017.11.002_bb0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/026988110101500212","article-title":"Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine","volume":"15","author":"Wilton","year":"2001","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.vascn.2017.11.002_bb0145","doi-asserted-by":"crossref","first-page":"e0167348","DOI":"10.1371\/journal.pone.0167348","article-title":"Electrophysiological characteristics of human iPSC-derived cardiomyocytes for the assessment of drug-induced Proarrhythmic potential","volume":"11","author":"Yamamoto","year":"2016","journal-title":"PLoS One"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871917302125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871917302125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:01:26Z","timestamp":1761004886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871917302125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":29,"alternative-id":["S1056871917302125"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2017.11.002","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}